No Data
No Data
Express News | 89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and com
89bio Up Over 12%, on Pace for Largest Percent Increase Since March 2023 -- Data Talk
89bio Inc ( ETNB ) is currently at $9.76, up $1.08 or 12.44% --Would be highest close since April 12, 2024, when it closed at $9.82 --On pace for largest percent increase since March 23, 2023, when
Express News | Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target
89bio Price Target Maintained With a $29.00/Share by HC Wainwright & Co.
89bio Price Target Maintained With a $29.00/Share by HC Wainwright & Co.
H.C. Wainwright Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $29
H.C. Wainwright analyst Ed Arce maintains $89bio(ETNB.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 40.0% and a total aver